Small Molecule Drug Product CDMO Benchmarking (9th Ed.)

Price range: $4,900.00 through $9,900.00

September 2026

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Report Overview

Small molecule pharmaceuticals remain a cornerstone of the global biopharma market, making outsourced drug product manufacturing one of the largest and most competitive segments of the CDMO industry. As sponsor companies navigate a crowded market, understanding what drives CDMO selection, and where providers stand relative to their competitors, has never been more important. This report examines current outsourcing practices, what drives provider selection, and offers an overview of the competitive landscape. In addition, the findings provide a data-driven view of how sponsors perceive their performance and where opportunities exist to strengthen differentiation and commercial positioning.

 

What you will learn:

Outsourcing Practices

  • Proportion of manufacturing activities outsourced
  • Main driver in outsourcing
  • Preferred provider usage and management

CDMO Selection Drivers

  • Top CDMO selection attributes
  • Key criteria driving CDMO selection
  • Selection attributes gaining importance

CDMO Perceptions & Interactions

  • CDMO brand awareness and familiarity
  • Perceived leadership, proposal volume, and CDMO preference
  • CDMO cost perceptions

CDMO Performance & Competitive Landscape

  • How CDMOs perform against sponsor expectations
  • Satisfaction and likelihood to reuse/recommend
  • Sponsor perceptions across competing providers

Company Service Quality Profiles

  • 20+ CDMO profiles
  • Customer feedback on 24 performance metrics
  • Includes metrics such as Loyalty, Performance against Expectations, Satisfaction verbatim and more

 

Included Providers:

Companies listed in bold print have a Company Service Quality Profile page detailing company performance based on user ratings (currently using or have used in the past 18 months).

  • AbbVie Contract Manufacturing
  • Adare Pharma Solutions
  • Alcami
  • Almac
  • Ardena
  • Bend Bioscience
  • Bora
  • BSP Pharmaceuticals
  • Carbogen Amcis
  • Catalent
  • CordenPharma
  • Curia
  • DPT
  • Evonik
  • Evotec
  • Famar
  • Fareva
  • Formulated Solutions
  • Glatt Pharmaceutical Services
  • Grand River Aspetic
  • Grifols
  • GSK Contract Manufacturing
  • Hetero
  • Hovione
  • Kindeva Drug Delivery
  • Lonza
  • MilliporeSigma
  • NextPharma
  • Pace Analytical
  • Patheon, by Thermo Fisher Scientific
  • PCI Pharma Services
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Pyramid Laboratories
  • Quotient Sciences
  • Recipharm
  • Resilience
  • Seran
  • Siegfried
  • Sterling Pharma Services
  • Unither Pharmaceuticals
  • Vetter
  • Wockhardt
  • WuXi STA

 

Respondents were required to pass several screening criteria to qualify and participate in this survey:

  • Must work at a biopharmaceutical company
  • Must have responsibilities in at least one of the following categories: clinical operations, clinical trial manufacturing, commercial manufacturing, executive management, outsourcing/purchasing management/supply chain, quality assurance/quality control, R&D management, regulatory compliance, or validation
  • Must have been involved in outsourced Small Molecule drug product within the past 18 months

Questions?

Our team is here to help.

For questions about syndicated report purchases, custom research solutions, or other billing-related topics, please contact sales@ISRreports.com.